Back to Search Start Over

An analysis of folic acid supplementation in women presenting for antenatal care.

Authors :
Cawley, Shona
Mullaney, Laura
McKeating, Aoife
Farren, Maria
McCartney, Daniel
Turner, Michael J.
Source :
Journal of Public Health; Mar2016, Vol. 38 Issue 1, p122-129, 8p
Publication Year :
2016

Abstract

Background Neural tube defects (NTDs) are major congenital malformations that are potentially preventable if the woman takes periconceptional folic acid (FA) supplements. A recent report found that NTD incidence had increased in Ireland. This study examined the usage of FA supplementation in women presenting for antenatal care in a maternity hospital. Methods Women were recruited at their convenience in the first trimester. Their clinical and sociodemographic details were computerized. Maternal weight and height were measured before calculating body mass index. Detailed FA questionnaires were completed under supervision of a trained researcher. Results While 96.1 %(n = 564) out of 587 reported that they took FA after they became pregnant, only 24.7% (n = 145) took it for .12 weeks preconceptionallyas recommended. Only 5.7% (n = 6) of obese women took high-dose FA as recommended. On univariate analysis, the strongest predictors of preconceptional FA usage were higher maternal age, higher education and income, being married, being nulliparous, not smoking, infertility treatment and planned pregnancy. On multivariate analysis, both planned pregnancy and nulliparity were the most important predictors of preconceptiona l FA use. Conclusions Our study shows that current recommendations to prevent NTDs by FA supplementation pre-pregnancyare not being fully implemented in Ireland. We recommend a review of current public health policies on FA supplementation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17413842
Volume :
38
Issue :
1
Database :
Complementary Index
Journal :
Journal of Public Health
Publication Type :
Academic Journal
Accession number :
113009737
Full Text :
https://doi.org/10.1093/pubmed/fdv019